News
Infant Bacterial Therapeutics secures partnership with BioConnection for production of Drug Product
Infant Bacterial Therapeutics AB (IBT) whose mission is to develop and commercialize pharmaceuticals for diseases affecting premature babies and…
Announcement: Mireille Sanders new member of Supervisory Board at BioConnection
Oss, NL May 20, 2025 BioConnection is pleased to announce the appointment of Mireille Sanders as member of our Supervisory Board. She succeeds…
BioConnection and Prestige Biologics
We noticed that various channels shared information about the legal proceedings between BioConnection B.V. and Prestige Biologics Co. Limited: On 11…
Successful IGJ inspection completed
We are proud to share that last week BioConnection successfully completed a three-day inspection by the Healthcare and Youth Inspectorate (IGJ),…
BioConnection Receives European CMO of the Year Award 2024 in (Bio)pharmaceuticals
BioConnection is excited to share that we’ve been named the European Company of the Year in Biopharmaceutical Contract Manufacturing 2024 by Pharma…
Announcement: Richard Sewalt new Chief Commercial Officer (CCO) at BioConnection
We are excited to announce that Richard Sewalt has joined BioConnection as our new Chief Commercial Officer (CCO). With his extensive background and…
BioConnection appoints Dr. Gary M. Phillips as the new Chairman of the Supervisory Board
BioConnection is pleased to announce the appointment of Dr. Gary M. Phillips as the new Chairman of the Supervisory Board. Dr. Phillips will succeed…
Strategic partnership AGC Biologics and BioConnection
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and BioConnection, a specialized…
BioConnection congratulates BioLineRx with their FDA approval of Aphexda
We are proud that we have been able to support BioLineRx since the start of the Motixafortide BL-8040 project (and even before) and be their proud…
Dutch CDMO BioConnection announces substantial investment by Gimv, supported by existing shareholders
New capital secures growth acceleration in services for small to medium sized biopharmaceutical companies and further enhancement of quality control…
BioConnection to manufacture clinical trial material for Nykode Therapeutics’ vaccine
BioConnection, an independent CDMO (Contract Development Manufacturing Organization) based in Oss, The Netherlands, specialized in GMP-certified…
GMP certification for new large scale filling line
BioConnection received today from the Dutch Healthcare Inspectorate (IGJ) the GMP certification and manufacturing license for their new large scale…
Let’s connect
If you’re exploring fill & finish support for an upcoming or ongoing program, we’d love to learn more about your goals and how we can contribute to your success. Whether you’re evaluating partners for a new project or preparing for your next development milestone, our team is ready to support you with clarity, expertise, and flexibility.
Share a few details about your molecule, timelines, or specific challenges, and we’ll follow up with insights tailored to your needs. By understanding your priorities early, we can determine how our capabilities, capacity, and approach align with your plans. We’re here to help.

















